Sodium ion channel mutations in glioblastoma patients correlate with shorter survival

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Joshi, Avadhut D ^a   Parsons, D W ^b,c   Velculescu, Victor E ^b   Riggins, Gregory J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DIGOXIN; OUABAIN; POTASSIUM CHANNEL; SODIUM CHANNEL;

5' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; INDEL MUTATION; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; SPLICING DEFECT; SURVIVAL TIME; BRAIN TUMOR; DRUG EFFECT; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

STROPHANTHUS GRATUS;

APOPTOSIS; BRAIN NEOPLASMS; CALCIUM CHANNELS; CELL LINE, TUMOR; CELL PROLIFERATION; DIGOXIN; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; OUABAIN; POTASSIUM CHANNELS; SODIUM CHANNELS; SURVIVAL ANALYSIS;

EID: 79751538060     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-17     Document Type: Article

References (22)

1. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG. Changing paradigms--an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11:165-180. 10.1634/theoncologist.11-2-165, 16476837.
2. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L, Brem H. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 2007, 83:61-70. 10.1007/s11060-006-9303-1, 17171441.
3. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 2008, 321:1807-1812. 10.1126/science.1164382, 2820389, 18772396.
4. Prevarskaya N, Skryma R, Bidaux G, Flourakis M, Shuba Y. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ 2007, 14:1295-1304. 10.1038/sj.cdd.4402162, 17479110.
5. MacFarlane SN, Sontheimer H. Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes. Glia 2000, 30:39-48. 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO;2-S, 10696143.
6. Knutson P, Ghiani CA, Zhou JM, Gallo V, McBain CJ. K+ channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 1997, 17:2669-2682.
7. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 2006, 25:493-500. 10.1007/s10555-006-9017-z, 17111226.
8. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005, 205:159-173. 10.1007/s00232-005-0781-4, 16362504.
9. Schonherr R. Clinical relevance of ion channels for diagnosis and therapy of cancer. J Membr Biol 2005, 205:175-184. 10.1007/s00232-005-0782-3, 16362505.
10. Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H, Battaloglu E, De Bella MT, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MB. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 2005, 11:5381-5389. 10.1158/1078-0432.CCR-05-0327, 16061851.
11. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001, 93:1246-1256. 10.1093/jnci/93.16.1246, 11504770.
12. Goldin AG, Safa AR. Digitalis and cancer. Lancet 1984, 1:1134. 10.1016/S0140-6736(84)92556-X, 6144872.
13. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007, 1776:32-57.
14. Stenkvist B. Is digitalis a therapy for breast carcinoma?. Oncol Rep 1999, 6:493-496.
15. Wang JK, Portbury S, Thomas MB, Barney S, Ricca DJ, Morris DL, Warner DS, Lo DC. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc Natl Acad Sci USA 2006, 103:10461-10466. 10.1073/pnas.0600930103, 1481664, 16793926.
16. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009, 360:765-773. 10.1056/NEJMoa0808710, 2820383, 19228619.
17. Diss JK, Stewart D, Pani F, Foster CS, Walker MM, Patel A, Djamgoz MB. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 2005, 8:266-273. 10.1038/sj.pcan.4500796, 16088330.
18. Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MB, Ke Y, Foster CS. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 1998, 423:19-24. 10.1016/S0014-5793(98)00050-7, 9506834.
19. Uysal-Onganer P, Djamgoz MB. Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3 M cells: involvement of voltage-gated sodium channel. Mol Cancer 2007, 6:76. 10.1186/1476-4598-6-76, 2211503, 18036246.
20. Lefranc F, Mijatovic T, Kondo Y, Sauvage S, Roland I, Debeir O, Krstic D, Vasic V, Gailly P, Kondo S, Blanco G, Kiss R. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008, 62:211-221. discussion 221-212, 10.1227/01.NEU.0000311080.43024.0E, 18300910.
21. Mijatovic T, Roland I, Van Quaquebeke E, Nilsson B, Mathieu A, Van Vynckt F, Darro F, Blanco G, Facchini V, Kiss R. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol 2007, 212:170-179. 10.1002/path.2172, 17471453.
22. Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling M, Holl GM, Patel MK, Sikes RA, Brown ML. Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Mol Cancer Ther 2003, 2:1149-1154.